Souheil Zayet to Betacoronavirus
This is a "connection" page, showing publications Souheil Zayet has written about Betacoronavirus.
Connection Strength
0.212
-
New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France. Int J Infect Dis. 2020 Nov; 100:117-122.
Score: 0.038
-
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes Infect. 2020 10; 22(9):500-503.
Score: 0.038
-
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes Infect. 2020 10; 22(9):481-488.
Score: 0.038
-
Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020. Emerg Infect Dis. 2020 Sep; 26(9).
Score: 0.038
-
Diarrhea: An underestimated symptom in Coronavirus disease 2019. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):282-283.
Score: 0.037
-
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):742-747.
Score: 0.009
-
Features of anosmia in COVID-19. Med Mal Infect. 2020 Aug; 50(5):436-439.
Score: 0.009
-
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients. Int J Infect Dis. 2020 Oct; 99:491-495.
Score: 0.002
-
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Med Mal Infect. 2020 Aug; 50(5):397-400.
Score: 0.002